Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 533212 | NSE Symbol : GKB | ISIN : INE265D01015 | Industry : Personal Care - Indian |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
24-Jan-2025	13-Feb-2025	Quarterly Results	GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2024. The Notice can be accessed at the Companys Website at www.gkb.net Further notices is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company by designated person under the SEBI (Prohibition of Insider Trading) Regulation 2015 which has been closed will now re- open on Monday February 17 2025. The meeting of the Board of Directors of the Company was held on February 13, 2025 which considered and took on record the unaudited standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2024. The above unaudited financial results and the limited review reports are available on the Company''s Website www.gkb.net and on BSE website www.bseindia.com. The Board of Director''s meeting started at 4:15 P.M. and ended at 4:55 P.M. , on the same day. Kindly take the information on record (As per BSE Announcement Dated on 13/02/2025)
03-Jan-2025	03-Jan-2025	Others	A meeting of the Board of Directors of the Company was held on January 03, 2025, which considered and approved the borrowing by way of an unsecured loan of upto Rs. 5.00 Crores ( Rupees Five Crores only) in tranches at rate of interest of 10.65% p.a. from GSV Ophthalmics Private Limited, a material subsidiary of the Company for the working capital requirements and general business purpose. Further, the Board of Directors approved and executed the Loan Agreement on January 03, 2025 between the Company and GSV Ophthalmics Private Limited for an amount of upto Rs. 5.00 Crores to be availed by the Company in tranches. Enclosed please find the details of the Loan Agreement. The meeting started at 11:35 A.M., and ended at 12.20 P.M. , on the same day. Kindly take the information on record.
30-Oct-2024	14-Nov-2024	Quarterly Results	GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30 2024. The Notice can be accessed at the Companys website at www.gkb.net Further notice is given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company by designated persons under the SEBI(Prohibition of Insider Trading ) Regulations 2015 which has been closed will now re-open on Monday November 18 2024. This communication has been sent to all the Directors and all the designated employees of the Company. The meeting of the Board of Directors of the company was held on November 14, 2024, which considered and took on record the Unaudited standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2024. The above Unaudited Financial Results and the Limited Review Reports are available on the Company''s website www.gkb.net and on the BSE website www.bseindia.com. The Board of Directors'' Meeting started at 04.15 P. M and ended at 05.05 P.M, on the same day. Kindly take the information on record (As per BSE Announcement Dated on 14/11/2024)
19-Jul-2024	13-Aug-2024	Quarterly Results	GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve the unaudited standalone and consolidated financial Results of the Company for the quarter ended June 30 2024. The Notice can be accessed at the Companys website at www.gkb.net Further notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company by designated persons under the SEBI (Prohibition of Insider Trading) Regulations 2015 had been closed from July 01 2024 will now re-open on Friday August 16 2024. This communication has been sent to all the Directors and all the designated employees of the Company The meeting of the Board of Directors of the Company was held on August 13, 2024, which considered and took on record the unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2024. Kindly take the above information on record. (As per BSE Announcement dated on 13/08/2024)
25-Apr-2024	30-May-2024	Accounts	GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31 2024. The notice can be accessed at the Companys website at www.gkb.net Further notice is hereby given with reference to the above meeting of the Board of Directors that the trading window for dealing with equity shares of the company by designated persons under SEBI (Prohibition of Insider Trading) Regulation 2015 had been closed from April 01 2024 will now re-open on MondayJune 03 2024. The meeting of the Board of Directors of the Company was held on May 30, 2024, which approved and took on record the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2024. Pursuant to Regulation 33 (3) (d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the following: 1. Standalone Financial Results for the quarter and year ended March 31, 2024, together with Auditors'' Report. 2. Consolidated Financial Results for the quarter and year ended March 31, 2024, together with Auditors'' Report. 3. A declaration from CFO with respect to Audit Report with unmodified opinion for the financial year ended March 31, 2024, in terms of SEBI Circular no. CIR/ CFD/CMD/56/2016 dated May 27, 2016. The above Audited Financial Results and Auditors'' Reports'' are available on the Company''s website www.gkb.net and on the BSE website www.bseindia.com Read less.. Dear Sir, Enclosed Please find the Audited Standalone and Consolidated Financials for the quarter and year ended March 31, 2024. Kindly take the information on record. (As Per BSE Announcement Dated on 30.05.2024)
22-May-2024	22-May-2024	Change in Directors	In compliance with the provisions of Regulation 30 read with Schedule III of SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors have passed circular resolutions today, i.e. May 22, 2024 with respect to 1. Appointment of Mrs. Sandhya Ajit Kamat as an Additional Director ( Independent & Non Executive), with effect from May 22, 2024. 2. Retirement of Mr. Anil Palekar , as Independent Non Executive Director of the Company with effect from close of business hours on May 22, 2024, due to completion of his tenure. 3. Reconstitution of the Committees of the Board of Directors. We request you to kindly take note of the same.
19-Mar-2024	19-Mar-2024	Others	A separate meeting of the Independent Directors of the Company for the year 2023-24 was held pursuant to Regulation 25(3) of SEBI ( Listing Obligations and Disclosure Requirements ) Regulations, 2015 and Section 149(8) of the Companies Act, 2013, read with Schedule IV(VII). All the Independent Directors were present. The details of the business transacted are enclosed. Kindly take the information on record. Pursuant to Regulation 30 of the Securities and Exchange Board of India ( Listing Obligations and Disclosure Requirements) Regulations, 2015 enclosed please find the disclosure pertaining to the resignation of Mr. Subhash Redkar as Executive / Whole Time Director of the Company w.e.f. March 16, 2024. The Board of Director in its meeting held today, i.e. March 19, 2024, accepted the resignation of Mr. Subhash Redkar as Executive/ Whole Time Director of the Company and thereafter reconstituted the Committees of the Board. The said details and a copy of the resignation letter is enclosed as Annexure A. Kindly take the information on record.
30-Jan-2024	14-Feb-2024	Quarterly Results	GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2023. The Notice can be accessed at the Companys website at www.gkb.net Further notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company by designated persons under the SEBI (Prohibition of Insider Trading) Regulations 2015 which has been closed will now re-open on Monday February 19 2024. This communication has been sent to all the Directors and all the designated employees of the Company. The meeting of the Board of Directors of the Company was held on February 14, 2024, which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company for quarter and nine months ended December 31, 2023. Pursuant to Regulation 33 (3)(d) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, enclosed please find the following : 1. Standalone Financial Results for the quarter and nine months ended December 31, 2023, together with the Limited Review Report. 2. Consolidated Financial Results for the quarter and nine months ended December 31, 2023, together with the Limited Review Report. The Board of Directors'' Meeting started at 4.45 P.M. and ended at 06.25 P.M., on the same day. Kindly take the information on record. (As Per BSE Announcement Dated on 14/02/2024)
30-Oct-2023	14-Nov-2023	Quarterly Results	GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve Notice is hereby given that a meeting of the Board of Directors of the company will be held on Tuesday November 14 2023 inter alia for considering and taking on record the Unaudited standalone and consolidated Financials Results of the Company for the quarter and half ended September 30 2023. The Notice can be accessed at the Companys website at www.gkb.net. Kindly take the information on record. The meeting of the Board of Directors of the Company was held on November 14, 2023, which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company quarter and half year ended September 30, 2023. Pursuant to Regulation 33 (3)(d) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, enclosed please find the following : 1. Standalone Financial Results for the quarter and half year ended September 30, 2023, together with the Limited Review Report. 2. Consolidated Financial Results for the quarter and half year ended September 30, 2023, along with Limited Review Report. The above Unaudited Financial Results and the Limited Review Reports are available on the Company''s website www.gkb.net and on the BSE website www.bseindia.com The Board of Directors'' Meeting started at 04.00 P.M. and ended at 06.45 P.M., on the same day. (As Per BSE Announcement dated on 14.11.2023)
27-Jul-2023	11-Aug-2023	Quarterly Results	GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2023. The Notice can be accessed at the Companys website at www.gkb.net Further notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company by designated persons under the SEBI (Prohibition of Insider Trading) Regulations 2015 which has been closed will now re-open on Monday August 14 2023. This communication has been sent to all the Directors and all the designated employees of the Company. The meeting of the Board of Directors of the Company was held on August 11, 2023, which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2023. Pursuant to Regulation 33 (3) (d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the following: 1. Standalone Financial Results for the quarter ended June 30, 2023, together with the Limited Review Report 2. Consolidated Financial Results for the quarter ended June 30, 2023, along with Limited Review Report. The above Unaudited Financial Results and the Limited Review Reports are available on the Company''s website www.gkb.net and on the BSE website www.bseindia.com . (As Per BSE Announcement Dated on 25.08.2023)
12-May-2023	30-May-2023	Accounts	GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31 2023. The Notice can be accessed at the Companys website at www.gkb.net Further notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company by designated persons under the SEBI (Prohibition of Insider Trading) Regulations 2015 had been closed from April 01 2023 will now re-open on Friday June 02 2023. This communication has been sent to all the Directors and all the designated employees of the Company. The meeting of the Board of Directors of the Company was held on May 30, 2023, which approved and took on record the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2023. Pursuant to Regulation 33 (3) (d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the following: 1. Standalone Financial Results for the quarter and year ended March 31, 2023, together with Auditors'' Report. 2. Consolidated Financial Results for the quarter and year ended March 31, 2023, along with Auditors'' Report. 3. A declaration from CFO with respect to Audit Report with unmodified opinion for the financial year ended March 31, 2023, in terms of SEBI Circular no. CIR/ CFD/CMD/56/2016 dated May 27, 2016. The above Audited Financial Results and Auditors'' Reports'' are available on the Company''s website www.gkb.net and on the BSE website www.bseindia.com. Pursuant to Regulation 30 of the SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Kulkarni and Bhat, Chartered Accountants ( Firm Registration No. 115960W), Internal Auditors of the Company, have have expressed their intent to resign from the post of Internal Auditor of the Company, from F.Y. 2023-24 onwards, due to professional engagements. The Audit Committee and Board of Directors of the Company have accepted the resignation at their respective meetings held on May 30, 2023. Also, as per the recommendation of the Audit Committee at its meeting held on May 30, 2023, the Board of Directors have considered and approved the appointment of RRK & Co.,Chartered Accountants as Internal Auditors of the Company. Details with respect to the change of Internal Auditors in terms of Regulation 30 read with Schedule III of the Listing Regulations and SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015 is also annexed herewith. (As Per BSE Announcement dated on 30.05.2023)
04-Mar-2023	13-Mar-2023	Others	Pursuant to Regulation 25(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a separate Meeting of the Independent Directors of the Company is scheduled to be held on Monday, March 13, 2023 at the Registered office of the Company situated at Plot No. 16-A , Tivim Industrial Estate, Mapusa, Goa , 403 526, to consider the following business: 1. To review the performance of Non-Independent Directors and the Board as a whole; 2. To review the performance of the Chairperson of the Company, taking into account the views of Executive Directors and Non-Executive Directors; 3. To assess the quality, quantity and timeliness of flow of information between the Company management and the Board that is necessary for the Board to effectively and reasonably perform their duties; 4. Any other business with the permission of chair. A separate meeting of the Independent Directors of the Company for the year 2022-23, was held, pursuant to Regulation 25(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and section 149(8) of the Companies Act, 2013, read with Schedule IV (VII). The following Independent Directors were present at the meeting: 1. Mr. Sadashiv Shet 2. Mr. Anil Palekar 3. Mrs. Shashi Katreddi Since all the Independent Directors were present, no leave of absence was granted. The Independent Directors in their Meeting held today: 1.Reviewed the performance of Non-Independent Directors and the Board as a whole. 2.Reviewed the performance of the Chairperson of the Company, taking into account the views of the Executive Director and Non-Executive Directors. 3.Assessed the quality, quantity and timeliness of the flow of information between the Company''s management and the Board. The Independent Directors'' Meeting started at 10:00 A.M. and ended at 10:40 A.M., on the same day. (As Per BSE Announcement Dated on 13.03.2023)
31-Jan-2023	14-Feb-2023	Quarterly Results	GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2022. The Notice can be accessed at the Companys website at www.gkb.net Further notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company by designated persons under the SEBI (Prohibition of Insider Trading) Regulations 2015 has been closed from January 01 2023 till the completion of 48 hours after the declaration of the said financial results of the Company. The Trading Window shall now re-open on Friday February 17 2023. This communication has been sent to all the Directors and all the designated employees of the Company. The meeting of the Board of Directors of the Company was held on February 14, 2023, which considered and took on record, the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2022. Pursuant to Regulation 33(3) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the following: 1. Standalone financial results for the quarter and nine months ended December 31, 2022, together with the Limited Review Report. . 2. Consolidated financial results for the quarter and nine months ended December 31, 2022, together with the Limited Review Report. The above Unaudited standalone and consolidated financial results and the limited review reports are available on the Company's website www.gkb.net and the BSE website www.bseindia.com . The Board of Directors' meeting commenced at 4:45 P.M. and concluded at 5:50 P.M. on the same day. (As Per BSE Announcement Dated on 14.02.2023)
27-Oct-2022	12-Nov-2022	Quarterly Results	GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30 2022. The Notice can be accessed at the Companys website at www.gkb.net Further notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company by designated persons under the SEBI (Prohibition of Insider Trading) Regulations 2015 has been closed from October 01 2022 till the completion of 48 hours after the declaration of the said financial results of the Company. The Trading Window shall now re-open on Tuesday November 15 2022. This communication has been sent to all the Directors and all the designated employees of the Company. The meeting of the Board of Directors of the Company was held on November 12, 2022, which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2022. Pursuant to Regulation 33 (3)(d) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, enclosed please find the following : 1. Standalone Financial Results for the quarter and half year ended September 30, 2022, together with the Limited Review Report. 2. Consolidated Financial Results for the quarter and half year ended September 30, 2022, along with Limited Review Report. The above Unaudited Financial Results and the Limited Review Reports are available on the Company''s website www.gkb.net and on the BSE website www.bseindia.com The Board of Directors'' Meeting started at 2:05 P.M and ended at 3:20 P.M., on the same day. (As Per BSE Announcement Dated 12.11.2022)
28-Jul-2022	12-Aug-2022	Quarterly Results	GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2022. The Notice can be accessed at the Companys website at www.gkb.net Further notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company by designated persons under the SEBI (Prohibition of Insider Trading) Regulations 2015 which has been closed will now re-open on Tuesday August 16 2022. This communication has been sent to all the Directors and all the designated employees of the Company. The meeting of the Board of Directors of the Company was held on August 12, 2022, which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2022. Pursuant to Regulation 33 (3) (d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find the following : 1. Standalone Financial Results for the quarter ended June 30, 2022, together with the Limited Review Report. 2. Consolidated Financial Results for the quarter ended June 30, 2022, along with Limited Review Report. The above Unaudited Financial Results and the Limited Review Reports are available on the Company''s website www.gkb.net and on the BSE website www.bseindia.com (As per BSE Announcement Dated on 12/08/2022)

1 2 3

LOGIN HERE

GKB Ophthalmics Ltd

Board Meeting